Capstone Investment Advisors
TEVA icon

Capstone Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Capstone Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-118,800
Closed -$1.07M – 1762
2020
Q3 		$1.07M Buy
+118,800
New +$1.26M 0.01% 997

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capstone Investment Advisors's TEVA Position: Q1 2024 in Review

Capstone Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2024, closing a stake of 12,730 shares — an estimated $133K sold.

Capstone Investment Advisors first reported a position in TEVA in Q1 2017 and held it in 3 quarters. The position peaked at $487K in Q2 2019. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Capstone Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 12,730 Teva Pharmaceutical Industries Limited shares in Q1 2024, an estimated $133K.
  • Capstone Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2017 and held it in 3 quarters.
  • Capstone Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $487K in Q2 2019.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2024.

Based on Capstone Investment Advisors's 13F filing for Q1 2024, filed 1 May 2024.